HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
4.300
-0.280 (-6.11%)
At close: Jul 2, 2026, 4:00 PM EDT
4.500
+0.200 (4.65%)
After-hours: Jul 2, 2026, 7:33 PM EDT
HCW Biologics Employees
HCW Biologics had 35 employees as of December 31, 2025. The number of employees decreased by 1 or -2.78% compared to the previous year.
Employees
35
Change (1Y)
-1
Growth (1Y)
-2.78%
Revenue / Employee
$188,348
Profits / Employee
-$517,652
Market Cap
5.13M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 35 | -1 | -2.78% |
| Dec 31, 2024 | 36 | -9 | -20.00% |
| Dec 31, 2023 | 45 | 1 | 2.27% |
| Dec 31, 2022 | 44 | 0 | - |
| Dec 31, 2021 | 44 | 4 | 10.00% |
| Mar 31, 2021 | 40 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| CollPlant Biotechnologies | 39 |
| PMGC Holdings | 34 |
| Aptevo Therapeutics | 33 |
| FibroBiologics | 15 |
| Soligenix | 14 |
| NuCana | 12 |
| Dermata Therapeutics | 9 |
HCWB News
- 5 days ago - HCW Biologics regains compliance with Nasdaq - TheFly
- 5 days ago - HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter - GlobeNewsWire
- 5 days ago - Hcw Biologics Inc trading halted, news pending - TheFly
- 9 days ago - HCW Biologics announces 1-for-6 reverse stock split - TheFly
- 9 days ago - HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026 - GlobeNewsWire
- 17 days ago - HCW Biologics Registration statement: Registration filing - Filings
- 19 days ago - HCW Biologics announces data from first two dose cohorts of HCW9302 trial - TheFly
- 19 days ago - HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata - GlobeNewsWire